Urological Oncology: Prostate Cancer
- 1 January 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (1) , 506-517
- https://doi.org/10.1097/01.ju.0000099169.01860.e5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Decreased gene expression of steroid 5 alpha‐reductase 2 in human prostate cancer: Implications for finasteride therapy of prostate carcinomaThe Prostate, 2003
- Verification Bias and the Prostate-Specific Antigen Test — Is There a Case for a Lower Threshold for Biopsy?New England Journal of Medicine, 2003
- The Prevention of Prostate Cancer — The Dilemma ContinuesNew England Journal of Medicine, 2003
- Urological Oncology: Prostate CancerJournal of Urology, 2002
- Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of AgingUrology, 2001
- Proliferative Inflammatory Atrophy of the ProstateThe American Journal of Pathology, 1999
- LONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, 1998
- Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Effect of Finasteride (MK-906) on Stage D Prostate CancerJournal of Urology, 1992
- Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*Journal of Clinical Endocrinology & Metabolism, 1990